{"transactions":[{"id":1475021,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89769,"kind":"person","name":"Lea Darrell Shane","position":1,"cik":"0001958526","reported_name":"Lea Darrell Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:02:59.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023."}],"balance_after":260000,"derivative":{"exercise_price":2.65,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001104659-24-072885","document":"tm2417520-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924072885/tm2417520-6_4seq1.xml","form_type":"4"}},{"id":1713994,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89769,"kind":"person","name":"Lea Darrell Shane","position":1,"cik":"0001958526","reported_name":"Lea Darrell Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-12-13T01:09:39.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan  at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023."}],"balance_after":100000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-23-125488","document":"tm2332764-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125488/tm2332764-3_4seq1.xml","form_type":"4"}},{"id":1713993,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89769,"kind":"person","name":"Lea Darrell Shane","position":1,"cik":"0001958526","reported_name":"Lea Darrell Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-12-13T01:09:39.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":39599,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39599,"source":{"system":"sec-edgar","filing":"0001104659-23-125488","document":"tm2332764-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125488/tm2332764-3_4seq1.xml","form_type":"4"}},{"id":2084950,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":89769,"kind":"person","name":"Lea Darrell Shane","position":1,"cik":"0001958526","reported_name":"Lea Darrell Shane","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-12-15T22:00:43.000Z","date":"2022-11-21","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.9,"expiration_date":"2032-11-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001140361-22-045712","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114036122045712/form4.xml","form_type":"4"}}]}